Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies

Hepatocellular carcinoma (HCC) is the most common liver tumor and among the deadliest cancers worldwide. Advanced HCC overall survival is meager and has not improved over the last decade despite approval of several tyrosine kinase inhibitors (TKi) for first and second-line treatments. The recent app...

Descripción completa

Detalles Bibliográficos
Autores principales: Giraud, Julie, Chalopin, Domitille, Blanc, Jean-Frédéric, Saleh, Maya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012774/
https://www.ncbi.nlm.nih.gov/pubmed/33815418
http://dx.doi.org/10.3389/fimmu.2021.655697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012774/
https://www.ncbi.nlm.nih.gov/pubmed/33815418
http://dx.doi.org/10.3389/fimmu.2021.655697

Ejemplares similares